Cargando…

MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology

There is a significant overlap between HIV infection and substance-use disorders. Dopamine (DA) is the most abundantly upregulated neurotransmitter in methamphetamine abuse, with receptors (DRD1-5) that are expressed by neurons as well as by a large diversity of cell types, including innate immune c...

Descripción completa

Detalles Bibliográficos
Autores principales: Basova, Liana V., Lindsey, Alexander, McGovern, Annemarie, Rosander, Ashley, Delorme-Walker, Violaine, ElShamy, Wael M., Pendyala, Ved Vasishtha, Gaskill, Peter Jesse, Ellis, Ronald J., Cherner, Mariana, Iudicello, Jennifer E., Marcondes, Maria Cecilia Garibaldi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304659/
https://www.ncbi.nlm.nih.gov/pubmed/37376663
http://dx.doi.org/10.3390/v15061363
_version_ 1785065561128960000
author Basova, Liana V.
Lindsey, Alexander
McGovern, Annemarie
Rosander, Ashley
Delorme-Walker, Violaine
ElShamy, Wael M.
Pendyala, Ved Vasishtha
Gaskill, Peter Jesse
Ellis, Ronald J.
Cherner, Mariana
Iudicello, Jennifer E.
Marcondes, Maria Cecilia Garibaldi
author_facet Basova, Liana V.
Lindsey, Alexander
McGovern, Annemarie
Rosander, Ashley
Delorme-Walker, Violaine
ElShamy, Wael M.
Pendyala, Ved Vasishtha
Gaskill, Peter Jesse
Ellis, Ronald J.
Cherner, Mariana
Iudicello, Jennifer E.
Marcondes, Maria Cecilia Garibaldi
author_sort Basova, Liana V.
collection PubMed
description There is a significant overlap between HIV infection and substance-use disorders. Dopamine (DA) is the most abundantly upregulated neurotransmitter in methamphetamine abuse, with receptors (DRD1-5) that are expressed by neurons as well as by a large diversity of cell types, including innate immune cells that are the targets of HIV infection, making them responsive to the hyperdopaminergic environment that is characteristic of stimulant drugs. Therefore, the presence of high levels of dopamine may affect the pathogenesis of HIV, particularly in the brain. The stimulation of HIV latently infected U1 promonocytes with DA significantly increased viral p24 levels in the supernatant at 24 h, suggesting effects on activation and replication. Using selective agonists to different DRDs, we found that DRD1 played a major role in activating viral transcription, followed by DRD4, which increased p24 with a slower kinetic rate compared to DRD1. Transcriptome and systems biology analyses led to the identification of a cluster of genes responsive to DA, where S100A8 and S100A9 were most significantly correlated with the early increase in p24 levels following DA stimulation. Conversely, DA increased the expression of these genes’ transcripts at the protein level, MRP8 and MRP14, respectively, which form a complex also known as calprotectin. Interestingly, MRP8/14 was able to stimulate HIV transcription in latent U1 cells, and this occurred via binding of the complex to the receptor for an advanced glycosylation end-product (RAGE). Using selective agonists, both DRD1 and DRD4 increased MRP8/14 on the surface, in the cytoplasm, as well as secreted in the supernatants. On the other hand, while DRD1/5 did not affect the expression of RAGE, DRD4 stimulation caused its downregulation, offering a mechanism for the delayed effect via DRD4 on the p24 increase. To cross-validate MRP8/14 as a DA signature with a biomarker value, we tested its expression in HIV+ Meth users’ postmortem brain specimens and peripheral cells. MRP8/14+ cells were more frequently identified in mesolimbic areas such as the basal ganglia of HIV+ Meth+ cases compared to HIV+ non-Meth users or to controls. Likewise, MRP8/14+ CD11b+ monocytes were more frequent in HIV+ Meth users, particularly in specimens from participants with a detectable viral load in the CSF. Overall, our results suggest that the MRP8 and MRP14 complex may serve as a signature to distinguish subjects using addictive substances in the context of HIV, and that this may play a role in aggravating HIV pathology by promoting viral replication in people with HIV who use Meth.
format Online
Article
Text
id pubmed-10304659
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103046592023-06-29 MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology Basova, Liana V. Lindsey, Alexander McGovern, Annemarie Rosander, Ashley Delorme-Walker, Violaine ElShamy, Wael M. Pendyala, Ved Vasishtha Gaskill, Peter Jesse Ellis, Ronald J. Cherner, Mariana Iudicello, Jennifer E. Marcondes, Maria Cecilia Garibaldi Viruses Article There is a significant overlap between HIV infection and substance-use disorders. Dopamine (DA) is the most abundantly upregulated neurotransmitter in methamphetamine abuse, with receptors (DRD1-5) that are expressed by neurons as well as by a large diversity of cell types, including innate immune cells that are the targets of HIV infection, making them responsive to the hyperdopaminergic environment that is characteristic of stimulant drugs. Therefore, the presence of high levels of dopamine may affect the pathogenesis of HIV, particularly in the brain. The stimulation of HIV latently infected U1 promonocytes with DA significantly increased viral p24 levels in the supernatant at 24 h, suggesting effects on activation and replication. Using selective agonists to different DRDs, we found that DRD1 played a major role in activating viral transcription, followed by DRD4, which increased p24 with a slower kinetic rate compared to DRD1. Transcriptome and systems biology analyses led to the identification of a cluster of genes responsive to DA, where S100A8 and S100A9 were most significantly correlated with the early increase in p24 levels following DA stimulation. Conversely, DA increased the expression of these genes’ transcripts at the protein level, MRP8 and MRP14, respectively, which form a complex also known as calprotectin. Interestingly, MRP8/14 was able to stimulate HIV transcription in latent U1 cells, and this occurred via binding of the complex to the receptor for an advanced glycosylation end-product (RAGE). Using selective agonists, both DRD1 and DRD4 increased MRP8/14 on the surface, in the cytoplasm, as well as secreted in the supernatants. On the other hand, while DRD1/5 did not affect the expression of RAGE, DRD4 stimulation caused its downregulation, offering a mechanism for the delayed effect via DRD4 on the p24 increase. To cross-validate MRP8/14 as a DA signature with a biomarker value, we tested its expression in HIV+ Meth users’ postmortem brain specimens and peripheral cells. MRP8/14+ cells were more frequently identified in mesolimbic areas such as the basal ganglia of HIV+ Meth+ cases compared to HIV+ non-Meth users or to controls. Likewise, MRP8/14+ CD11b+ monocytes were more frequent in HIV+ Meth users, particularly in specimens from participants with a detectable viral load in the CSF. Overall, our results suggest that the MRP8 and MRP14 complex may serve as a signature to distinguish subjects using addictive substances in the context of HIV, and that this may play a role in aggravating HIV pathology by promoting viral replication in people with HIV who use Meth. MDPI 2023-06-13 /pmc/articles/PMC10304659/ /pubmed/37376663 http://dx.doi.org/10.3390/v15061363 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Basova, Liana V.
Lindsey, Alexander
McGovern, Annemarie
Rosander, Ashley
Delorme-Walker, Violaine
ElShamy, Wael M.
Pendyala, Ved Vasishtha
Gaskill, Peter Jesse
Ellis, Ronald J.
Cherner, Mariana
Iudicello, Jennifer E.
Marcondes, Maria Cecilia Garibaldi
MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title_full MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title_fullStr MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title_full_unstemmed MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title_short MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology
title_sort mrp8/14 is a molecular signature triggered by dopamine in hiv latent myeloid targets that increases hiv transcription and distinguishes hiv+ methamphetamine users with detectable csf viral load and brain pathology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304659/
https://www.ncbi.nlm.nih.gov/pubmed/37376663
http://dx.doi.org/10.3390/v15061363
work_keys_str_mv AT basovalianav mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT lindseyalexander mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT mcgovernannemarie mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT rosanderashley mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT delormewalkerviolaine mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT elshamywaelm mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT pendyalavedvasishtha mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT gaskillpeterjesse mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT ellisronaldj mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT chernermariana mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT iudicellojennifere mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology
AT marcondesmariaceciliagaribaldi mrp814isamolecularsignaturetriggeredbydopamineinhivlatentmyeloidtargetsthatincreaseshivtranscriptionanddistinguisheshivmethamphetamineuserswithdetectablecsfviralloadandbrainpathology